Patents by Inventor Philippe Marianneau

Philippe Marianneau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VACCINE
    Publication number: 20120045469
    Abstract: The present invention provides an immunogenic composition comprising: an immunogenic SARS coronavirus S (spike) polypeptide, or a fragment or variant thereof; and an adjuvant comprising an oil-in-water emulsion.
    Type: Application
    Filed: December 1, 2009
    Publication date: February 23, 2012
    Applicant: GlaxoSmithKline Biologicals S.A.
    Inventors: Benoit Baras, Benoit Callendret, Nicolas Escriou, Valerie Lorin, Philippe Marianneau, Sylvie Van Der Werf, Martine Anne Cecile Wettendorff
  • VACCINE
    Publication number: 20100233250
    Abstract: The present invention provides a vaccine or immunogenic composition comprising: an immunogenic SARS coronavirus S (spike) polypeptide, or a fragment or variant thereof; and an adjuvant comprising a lipopolysaccharide, a saponin and a liposome.
    Type: Application
    Filed: June 20, 2008
    Publication date: September 16, 2010
    Inventors: Benoit Baras, Benoit Callendret, Nicolas Escriou, Valerie Lorin, Philippe Marianneau, Sylvie Van Der Werf, Martine Anne Cecile Wettendorff
  • Use of golden hamster as infectivity model of SARS
    Publication number: 20060143719
    Abstract: A model system for sudden acute respiratory syndrome infection (SARS) in humans, comprising a non-human animal infected with a SARS-causing coronavirus (CoV), wherein the non-human animal is a golden hamster.
    Type: Application
    Filed: August 16, 2005
    Publication date: June 29, 2006
    Inventors: Philippe Marianneau, Vincent Deubel, Hugues Contamin, Ingrid Marendat, Philippe Loth, Marie Georges-Courbot